Article
AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort.
International journal of molecular sciences - 9 May 2026
Rahahlah Nuseibah, Al-Alami Zina, Alorjani Mohammed S, Al-Smadi Asmaa, Obeidat Sewar, Otoom Raed, Al-Zoubi Raed M, Al Bashir Samir, Al Zoubi Mazhar Salim
Abstract excerpt
The AKT2 gene, located on chromosome 19, encodes a protein involved in key cellular processes like metabolism, proliferation, and survival. Abnormalities in the PI3K/AKT pathway, including AKT2, contribute to tumor progression. AKT2 promotes cell survival, growth, and resistance to therapy. Overexpression or hyperactivation of AKT2 is linked to prostate cancer (PC) development, making it a potential therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
